In this study, we revealed that DLX4 could regulate the expression of P53, P21, and PTEN via CKS2 in NSCLC cells, and we speculated that DLX4 could affect the viability and tumor growth of NSCLC by mediating CKS2. Here, PTEN is linked to non-small cell lung carcinoma.